BetterLife Pharma is seeking $500,000 in private placement

Betterlife Pharma Inc. (TSE: REGARD) has released an update.

BetterLife Pharma Inc., a biotech company specializing in non-hallucinogenic, LSD-based treatments for mental disorders, has announced plans for a non-brokered private placement with the aim of raising $500,000. These funds are intended to advance the development of their lead drug candidate, BETR-001, and for general corporate purposes. The offering includes common shares and warrants, with the closing date to be announced upon completion.

For more insight into TSE:BETR stock, check out TipRanks’ Stock Analysis Page.